University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma

Not Applicable

Recruiting

Conditions: Multiple Myeloma in Relapse
Aggressive Lymphoma
Multiple Myeloma Stage III
Multiple Myeloma Progression
Multiple Myeloma
Multiple Myeloma, Refractory
B Cell Lymphoma
Lymphoma, B-Cell

Interventions: Other: Early Palliative Care

First Posted Date: 2024-07-03

Last Posted Date: 2024-08-29

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 80

Registration Number: NCT06485076

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Canada

i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

Phase 2

Recruiting

Conditions: Major Depressive Disorder
Suicide
Treatment Resistant Depression

Interventions: Drug: Ketamine hydrochloride
Drug: Midazolam Hydrochloride
Behavioral: i-CBT (Internet-based Cognitive Behavioural Therapy)

First Posted Date: 2024-06-28

Last Posted Date: 2024-06-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 110

Registration Number: NCT06480500

Locations: 🇨🇦
Ontario Shores Centre for Mental Health Sciences, Whitby, Ontario, Canada
🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Activity-Based Therapy and Transcutaneous Spinal Cord Stimulation After Spinal Cord Injury (ABT-TCSCS)

Not Applicable

Recruiting

Conditions: Spinal Cord Injuries
Spinal Cord Injury Cervical

Interventions: Other: Activity-based therapy and transcutaneous spinal cord stimulation

First Posted Date: 2024-06-25

Last Posted Date: 2024-07-09

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 24

Registration Number: NCT06472986

Locations: 🇨🇦
Toronto Rehabilitation Institute, Toronto, Ontario, Canada

EXercise Enhancement After RadioTherapy for Bone Metastases

Not Applicable

Not yet recruiting

Conditions: Bone Metastases

First Posted Date: 2024-06-24

Last Posted Date: 2024-06-24

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT06470503

Feasibility of CALM in Patients With Ovarian Cancer

Not Applicable

Recruiting

Conditions: Patient Satisfaction
Ovarian Cancer

Interventions: Other: Managing Cancer And Living Meaningfully (CALM)

First Posted Date: 2024-06-14

Last Posted Date: 2024-07-16

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 50

Registration Number: NCT06459271

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Online Psychology Program for Chronic Pain After Surgery

Not Applicable

Not yet recruiting

Conditions: Pain, Acute
Pain, Chronic
Post-Surgical Pain, Chronic
Post-surgical Pain

Interventions: Other: Treatment As Usual
Device: Self-Guided Online ACT Program

First Posted Date: 2024-06-12

Last Posted Date: 2024-06-12

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT06455345

Locations: 🇨🇦
University Health Network- Toronto General Hospital, Toronto, Ontario, Canada

A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Device: Irreversible Electroporation (NanoKnife)

First Posted Date: 2024-06-11

Last Posted Date: 2024-06-11

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT06451445

Locations: 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada

TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study

Phase 4

Not yet recruiting

Conditions: Venous Thromboembolism
Anticoagulants and Bleeding Disorders
Venous Thromboses
Heavy Menstrual Bleeding

Interventions: Other: No Tranexamic acid
Drug: Tranexamic acid

First Posted Date: 2024-06-11

Last Posted Date: 2024-06-12

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 20

Registration Number: NCT06452342

A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment

Phase 2

Not yet recruiting

Conditions: Locally Advanced Pancreatic Adenocarcinoma

First Posted Date: 2024-06-11

Last Posted Date: 2024-11-14

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 43

Registration Number: NCT06453486

Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition

Phase 2

Not yet recruiting

Conditions: Post COVID Condition
Post Acute Sequelae of COVID-19
Long COVID

Interventions: Device: Hyperbaric Oxygen therapy

First Posted Date: 2024-06-11

Last Posted Date: 2024-12-06

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 120

Registration Number: NCT06452095

Home Terms & Conditions Privacy Policy